SSY Group obtains NMPA approval for fat-soluble vitamin injection
Published on 05/06/2026 at 12:15 pm +04
Reuters
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.240 HKD | -2.61% |
|
-3.03% | -20.85% |
Employees
5,472
Sector
Pharmaceuticals
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
BBB
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.300HKD
Average target price
3.760HKD
Spread / Average Target
+63.48%
Annual profits - Rate of surprise
- Stock Market
- Stock Market News
- SSY Group obtains NMPA approval for fat-soluble vitamin injection
Select your edition
All financial news and data tailored to specific country editions
